{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:18Z","timestamp":1789885218774,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["U19AI109946-01"],"award-info":[{"award-number":["U19AI109946-01"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["U19AI082724"],"award-info":[{"award-number":["U19AI082724"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["P01AI097092-03"],"award-info":[{"award-number":["P01AI097092-03"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["U19AI057266-11"],"award-info":[{"award-number":["U19AI057266-11"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["1R01AI117287"],"award-info":[{"award-number":["1R01AI117287"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["1R01AI128821"],"award-info":[{"award-number":["1R01AI128821"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["U19AI109946"],"award-info":[{"award-number":["U19AI109946"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.it.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T22:22:45Z","timestamp":1504218165000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":271,"title":["From Original Antigenic Sin to the Universal Influenza Virus Vaccine"],"prefix":"10.1016","volume":"39","author":[{"given":"Carole","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karin E.","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2017.08.003_bib0005","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2017.08.003_bib0010","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1073\/pnas.78.12.7639","article-title":"Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus","volume":"78","author":"Air","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003657","article-title":"New world bats harbor diverse influenza A viruses","volume":"9","author":"Tong","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2017.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.1218509110","article-title":"Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-U","article-title":"Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983","volume":"175","author":"Rota","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.it.2017.08.003_bib0030","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1073\/pnas.79.15.4800","article-title":"Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes","volume":"79","author":"Krystal","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2017.08.003_bib0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0050","first-page":"301","article-title":"Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin","volume":"386","author":"Krammer","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","article-title":"Immune history and influenza virus susceptibility","volume":"22","author":"Cobey","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0060","first-page":"572","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc. Am. Philos. Soc."},{"key":"10.1016\/j.it.2017.08.003_bib0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.98.6.641","article-title":"Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus","volume":"98","author":"Davenport","year":"1953","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(55)93328-6","article-title":"Epidemiology of influenza; comparative serological observations in England and the United States","volume":"269","author":"Davenport","year":"1955","journal-title":"Lancet"},{"key":"10.1016\/j.it.2017.08.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.it.2017.08.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0248","article-title":"Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza","volume":"370","author":"Zarnitsyna","year":"2015","journal-title":"Philos. Trans R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.it.2017.08.003_bib0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fimmu.2017.00238","article-title":"Epitope-specific suppression of IgG responses by passively administered specific IgG: evidence of epitope masking","volume":"8","author":"Bergstrom","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0090","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.vaccine.2004.08.053","article-title":"Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination","volume":"23","author":"Gulati","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2017.08.003_bib0095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2017.08.003_bib0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2017.08.003_bib0105","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1256427","article-title":"Antibody landscapes after influenza virus infection or vaccination","volume":"346","author":"Fonville","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0110","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.124.3.331","article-title":"Disquisitions of original antigenic sin. I. Evidence in man","volume":"124","author":"Fazekas de St","year":"1966","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0120","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.140.6.1571","article-title":"Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes","volume":"140","author":"Virelizier","year":"1974","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0125","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1073\/pnas.0912458109","article-title":"Strategies to alleviate original antigenic sin responses to influenza viruses","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002802","article-title":"Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China","volume":"8","author":"Lessler","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2017.08.003_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002082","article-title":"Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data","volume":"13","author":"Kucharski","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2017.08.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006637","article-title":"Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis","volume":"5","author":"Miller","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/CVI.00396-10","article-title":"Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands","volume":"18","author":"Bodewes","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0150","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","article-title":"Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting","volume":"354","author":"Gostic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"18","author":"Nachbagauer","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0160","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2105\/AJPH.37.8.1013","article-title":"Experience with vaccination against influenza in the spring of 1947: a preliminary report","volume":"37","author":"Francis","year":"1947","journal-title":"Am. J. Public Health Nations Health"},{"key":"10.1016\/j.it.2017.08.003_bib0165","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20130212","article-title":"Immune history shapes specificity of pandemic H1N1 influenza antibody responses","volume":"210","author":"Li","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0170","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1073\/pnas.1409171111","article-title":"Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013\u20132014 influenza season","volume":"111","author":"Linderman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0175","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/infdis\/jiw479","article-title":"Antibodies against the current influenza A(H1N1) vaccine strain do not protect some individuals from infection with contemporary circulating influenza A(H1N1) virus strains","volume":"214","author":"Petrie","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2017.08.003_bib0180","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/JVI.02371-10","article-title":"Vaccination against seasonal influenza A\/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A\/H5N1 virus infection in ferrets","volume":"85","author":"Bodewes","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005806","article-title":"Antibodies with \u2018original antigenic sin\u2019 properties are valuable components of secondary immune responses to influenza viruses","volume":"12","author":"Linderman","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2017.08.003_bib0190","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.it.2017.08.003_bib0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1128\/CVI.00790-13","article-title":"Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus","volume":"21","author":"O\u2019Donnell","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/infdis\/jis745","article-title":"Age- and sex-specific mortality associated with the 1918\u20131919 influenza pandemic in Kentucky","volume":"207","author":"Viboud","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2017.08.003_bib0205","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0210","doi-asserted-by":"crossref","first-page":"8107","DOI":"10.1073\/pnas.1324197111","article-title":"Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus","volume":"111","author":"Worobey","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0215","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI74374","article-title":"Preexisting human antibodies neutralize recently emerged H7N9 influenza strains","volume":"125","author":"Henry Dunand","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2017.08.003_bib0220","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0230","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1172\/JCI81104","article-title":"Focused antibody response to influenza linked to antigenic drift","volume":"125","author":"Huang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2017.08.003_bib0235","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S0264-410X(02)00131-7","article-title":"Influenza haemagglutinin","volume":"20","author":"Skehel","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2017.08.003_bib0240","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/JVI.00420-14","article-title":"Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses","volume":"88","author":"Iba","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0245","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.1218256109","article-title":"Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody","volume":"110","author":"Schmidt","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003067","article-title":"Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses","volume":"8","author":"Tsibane","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2017.08.003_bib0260","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.it.2017.08.003_bib0265","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0270","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.it.2017.08.003_bib0285","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0042-6822(83)90465-8","article-title":"Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants","volume":"126","author":"Graves","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.it.2017.08.003_bib0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2017.08.003_bib0295","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0300","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1073\/pnas.1319058110","article-title":"A common solution to group 2 influenza virus neutralization","volume":"111","author":"Friesen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0305","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1128\/JVI.02289-14","article-title":"Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin","volume":"88","author":"Tan","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0310","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/JVI.00469-12","article-title":"A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo","volume":"86","author":"Tan","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0315","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0320","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.it.2017.08.003_bib0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.it.2017.08.003_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025797","article-title":"H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination","volume":"6","author":"Moody","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2017.08.003_bib0335","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1128\/JVI.03509-12","article-title":"H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0340","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/infdis\/jiw608","article-title":"Induction of broadly cross-reactive stalk-specific antibody responses to influenza group 1 and group 2 hemagglutinins by natural H7N9 virus infection in humans","volume":"215","author":"Liu","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2017.08.003_bib0345","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/jis652","article-title":"1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans","volume":"207","author":"Miller","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2017.08.003_bib0350","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir121","article-title":"Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies","volume":"52","author":"Sui","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.it.2017.08.003_bib0355","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/CVI.00735-12","article-title":"B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination","volume":"20","author":"Sangster","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fimmu.2012.00087","article-title":"Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem","volume":"3","author":"Thomson","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0365","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0370","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chom.2015.10.003","article-title":"The quest for a universal flu vaccine: headless HA 2.0","volume":"18","author":"Krammer","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2017.08.003_bib0375","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coviro.2016.02.002","article-title":"Novel universal influenza virus vaccine approaches","volume":"17","author":"Krammer","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0380","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1099\/0022-1317-77-7-1483","article-title":"The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region","volume":"77","author":"Sagawa","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0385","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.it.2017.08.003_bib0390","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.vaccine.2015.05.038","article-title":"Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses","volume":"33","author":"Wohlbold","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.it.2017.08.003_bib0395","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"Mallajosyula","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2017.08.003_bib0400","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2017.08.003_bib0405","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.it.2017.08.003_bib0410","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2017.08.003_bib0415","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0420","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0425","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0430","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079194","article-title":"Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies","volume":"8","author":"Goff","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2017.08.003_bib0440","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.it.2017.08.003_bib0445","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01996-15","article-title":"Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans","volume":"7","author":"Nachbagauer","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.it.2017.08.003_bib0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004615","article-title":"Is antigenic sin always \u2018original?\u2019 Re-examining the evidence regarding circulation of a human H1 influenza virus immediately prior to the 1918 Spanish flu","volume":"11","author":"Gagnon","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2017.08.003_bib0455","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1128\/JVI.02871-14","article-title":"High preexisting serological antibody levels correlate with diversification of the influenza vaccine response","volume":"89","author":"Andrews","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0460","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/CVI.00272-14","article-title":"An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans","volume":"21","author":"Krammer","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.it.2017.08.003_bib0465","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2017.08.003_bib0470","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/jiv210","article-title":"High-affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine","volume":"212","author":"Halliley","year":"2015","journal-title":"J. Infect. Dis."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490617301643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490617301643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T02:36:40Z","timestamp":1535423800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490617301643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1471490617301643"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2017.08.003","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Original Antigenic Sin to the Universal Influenza Virus Vaccine","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}